Ricoh Moves Firmly into Biotech with Elixirgen Scientific Acquisition


On May 17, Ricoh announced that it agreed to acquire a majority stake in a Baltimore, MD, biotech company that develops drug discovery products and services. Ricoh said that with its new subsidiary, Elixirgen Scientific, the company plans to grow its emerging biomedical operations into a ¥20 billion ($186 million) business by 2025. In 2019,

To see the rest of this post, please view membership options or log in to your account below.


error: Alert: Content is protected !!